ReviewFrontiers in immunology2024

Advancements in cancer immunotherapies targeting CD20: from pioneering monoclonal antibodies to chimeric antigen receptor-modified T cells.

Agnieszka Dabkowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.